arrow
S

Siddhartha Ganguly

Neal Cancer Center
H指数:47
被引数:7,887

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis

Idecabtagene vicleucel治疗后100天内感染及其对复发/难治性多发性骨髓瘤患者生存的影响:CIBMTR分析

2026-06-270
PRE
Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis

嵌合抗原受体T细胞疗法治疗Richter转化:一项CIBMTR分析

2025-08-050
PRE
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

CD19嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后的感染:CIBMTR的真实世界分析

2025-05-300
OAAI
Statins May Improve Outcomes and Toxicities in Patients Undergoing CD19-Specific CAR T-Cell Therapy for Aggressive B-Cell Lymphomas

他汀类药物可能改善接受CD19特异性CAR T细胞疗法治疗侵袭性B细胞淋巴瘤患者的结局和毒副作用。

BLOOD
IF23.1
2024-11-050
PRE
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with nonmalignant disorders: a retrospective cohort study
2024-10-011
PRE
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study
2024-08-142
OAAI
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
2023-11-177
OAAI
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

≥ 1年异基因造血干细胞移植幸存者长期结果的种族和社会经济差异: CIBMTR分析

2023-11-016
PRE
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
2023-07-288
OAAI
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients (oct, 10.1038/s41375-022-01738-3, 2022)
LEUKEMIA
IF13.4
2023-03-220
OA
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
2023-02-0920
OAAI
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
LEUKEMIA
IF13.4
2022-10-3011
OA